HCAT logo

Health Catalyst Inc (HCAT)

$2.46

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on HCAT

Market cap

$173997975

EPS

-1.59

P/E ratio

--

Price to sales

0.55

Dividend yield

--

Beta

1.728573

Price on HCAT

Previous close

$2.56

Today's open

$2.56

Day's range

$2.44 - $2.62

52 week range

$2.02 - $8.50

Profile about HCAT

CEO

Daniel Burton

Employees

728

Headquarters

South Jordan, UT

Exchange

Nasdaq Global Select

Shares outstanding

70730884

Issue type

Common Stock

HCAT industries and sectors

Healthcare

Healthcare Providers & Services

News on HCAT

Matt Arens, CEO and Founder of Health Catalyst's Largest Shareholder, First Light Asset Management, Joins Board of Directors

SALT LAKE CITY , Dec. 2, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst" or the "Company," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Matt Arens, CEO and Founder of First Light Asset Management, LLC ("First Light"), has been appointed to serve as a member of Health Catalyst's board of directors ("Board"), effective Dec. 1, 2025. A shareholder since Health Catalyst's IPO in 2019, First Light is the Company's largest shareholder, and First Light and Mr.

news source

PRNewsWire • Dec 2, 2025

news preview

Health Catalyst to Participate in Upcoming Investor Conferences

SALT LAKE CITY, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that members of senior management will participate in the following upcoming investor conferences: The Stephens Annual Investment Conference, being held in Nashville, including a fireside chat with Ben Albert, President and Chief Operating Officer, Jason Alger, Chief Financial Officer, and Matt Hopper, SVP of Finance and Head of Investor Relations, on Wednesday, November 19, 2025 at 3:00pm CT. The Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum, being held in New York, including 1x1 meeting opportunities with Dan Burton, Chief Executive Officer, Ben Albert, President and Chief Operating Officer, Jason Alger, Chief Financial Officer, and Matt Hopper, SVP of Finance and Head of Investor Relations, on Thursday, November 20, 2025.

news source

GlobeNewsWire • Nov 14, 2025

news preview

Health Catalyst, Inc. (HCAT) Q3 2025 Earnings Call Transcript

Health Catalyst, Inc. ( HCAT ) Q3 2025 Earnings Call November 10, 2025 5:00 PM EST Company Participants Matt Hopper Daniel Burton - CEO & Director Benjamin Albert - President & COO Jason Alger - Chief Financial Officer Conference Call Participants Jared Haase - William Blair & Company L.L.C., Research Division Jessica Tassan - Piper Sandler & Co., Research Division Elizabeth Anderson - Evercore ISI Institutional Equities, Research Division Richard Close - Canaccord Genuity Corp., Research Division Daniel Grosslight - Citigroup Inc., Research Division David Larsen - BTIG, LLC, Research Division Stanislav Berenshteyn - Wells Fargo Securities, LLC, Research Division Jeffrey Garro - Stephens Inc., Research Division Gabrielle Ingoglia - Cantor Fitzgerald & Co., Research Division Presentation Operator Welcome to the Health Catalyst Third Quarter 2025 Earnings Conference Call.

news source

Seeking Alpha • Nov 11, 2025

news preview

Health Catalyst Reports Third Quarter 2025 Results

SALT LAKE CITY, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended September 30, 2025. “For the third quarter of 2025, I am pleased by our financial results, including total revenue of $76.3 million and Adjusted EBITDA of $12.0 million, with these results beating our quarterly guidance on each measure,” said Dan Burton, CEO of Health Catalyst.

news source

GlobeNewsWire • Nov 10, 2025

news preview

Health Catalyst (HCAT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Health Catalyst (HCAT) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

news source

Zacks Investment Research • Nov 11, 2025

news preview

Health Catalyst (HCAT) Q3 Earnings and Revenues Top Estimates

Health Catalyst (HCAT) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.07 per share a year ago.

news source

Zacks Investment Research • Nov 11, 2025

news preview

Health Catalyst Achieves HITRUST r2 Certification, Demonstrating the Highest Level of Information Protection Assurance

SALT LAKE CITY , Nov. 10, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Twistle by Health Catalyst (Twistle), Lumeon by Health Catalyst (Lumeon), and Upfront by Health Catalyst (Upfront) have earned certified status by HITRUST for information security. HITRUST r2 Certification demonstrates that Twistle, Lumeon, and Upfront have met demanding regulatory compliance and industry-defined requirements that assess whether offerings are appropriately managing risk.

news source

PRNewsWire • Nov 10, 2025

news preview

UnityPoint Health to Unlock Next Phase of Analytics Innovation by Activating Health Catalyst Ignite™

SALT LAKE CITY , Nov. 10, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that UnityPoint Health, an integrated non-profit health system that provides care throughout Iowa, western Illinois and southern Wisconsin in not-for-profit hospitals, clinics, and home health settings, is set to migrate from Health Catalyst's legacy data platform to its modern data platform, Health Catalyst Ignite™ Data and Analytics. Since beginning their partnership in 2016, UnityPoint Health has realized meaningful and measurable improvements through Health Catalyst's legacy data and analytics platform.

news source

PRNewsWire • Nov 10, 2025

news preview

Health Catalyst (HCAT) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Besides Wall Street's top-and-bottom-line estimates for Health Catalyst (HCAT), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2025.

news source

Zacks Investment Research • Nov 6, 2025

news preview

Impax Small Cap Fund Q3 2025 Contributors And Detractors

Ligand Pharmaceuticals (LGND) (Health Care, Pharmaceuticals) shares rose after announcing adjusted earnings per share that came in ahead of consensus. Acadian Asset Management (AAMI) (Financials, Asset Management & Custody Banks) saw another quarter of better-than-expected flows, driving earnings upside relative to expectations. SI-Bone (SIBN) (Health Care, Health Care Equipment) was weaker despite reporting a marginal beat on revenue and expectations of improved profitability.

news source

Seeking Alpha • Oct 28, 2025

news preview

¹ Disclosures

Get started with M1

Invest in Health Catalyst Inc

Open an M1 investment account to buy and sell Health Catalyst Inc commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in HCAT on M1